High-profile lawsuits and SEC investigations over cash sweeps have taken the industry by storm.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.
If similar cases are a guide, the US has given equal weight to both known and hypothetical threats to national security.
With Trump expected to chase increased oil exports and more drilling in the US, OPEC+’s fear of losing market share looms larger than ever.